Abeona Therapeutics (ABEO) s Set to Breakeven—And Analysts Say It’s Just the Beginning
Abeona Therapeutics Inc. (NASDAQ:ABEO) is a clinical-stage biopharmaceutical company pioneering gene and cell therapies aimed at treating rare…
Browsing Tag